Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Clindamycin Mylan Clindamycin phosphate 197.88mg/mL equivalent to clindamycin 150mg/mL Solution for injection Mylan New Zealand Limited Mylan Teoranta, Kilroe East, Galway, Ireland
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturers:
|
Paracetamol Kabi Paracetamol 10mg/mL Solution for injection Fresenius Kabi New Zealand Limited Fresenius Kabi Austria GmbH, Graz, Austria Fresenius Kabi France, Louviers, France Fresenius Kabi Norge AS, Halden, Norway Fresenius Kabi Deutschland GmbH, Friedberg, Germany
|
Product: Active Ingredients:
Dosage Form: New Zealand Sponsor: Manufacturer:
|
Simbrinza Brimonidine tartrate 2mg/mL Brinzolamide 10mg/mL Eye drops, suspension Alcon Laboratories SA Alcon Couvreur NV, Puurs, Belgium
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Tranexamic-AFT Tranexamic acid 100mg/mL Solution for injection AFT Pharmaceuticals Limited Labiana Pharmaceuticals SL, Barcelona, Spain
|
Dated this 30th day of June 2016.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).